Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1992 | 09-1992 | 06-1992 | 03-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 440 | 124 | N/A |
| Marketable Securities | 120 | 260 | 0 | 0 | 270 |
| Receivables | 10 | 10 | 45 | 49 | 40 |
| Inventories | 6 | 5 | 4 | 5 | 10 |
| Other current assets | 14 | 5 | 30 | 0 | 0 |
| TOTAL | $150 | $280 | $519 | $178 | $320 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 10 | 10 | 11 | 11 | 10 |
| TOTAL | $10 | $10 | $11 | $11 | $10 |
| Total Assets | $310 | $460 | $706 | $377 | $530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 213 | 177 | 0 |
| Accrued Expenses | 6 | N/A | 6 | 6 | 6 |
| Other current liabilities | N/A | N/A | 541 | 60 | N/A |
| TOTAL | $170 | $210 | $760 | $243 | $240 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
| Other Non-Current Liabilities | 0 | 6 | 0 | 0 | 0 |
| TOTAL | $1,500 | $1,506 | $1,500 | $1,500 | $1,500 |
| Total Liabilities | $1,670 | $1,710 | $2,260 | $1,743 | $1,740 |
| Shareholders' Equity | |||||
| Common Shares | 120 | 120 | 118 | 117 | 110 |
| Retained earnings | -18,560 | -18,380 | -18,183 | -17,932 | -17,770 |
| Other shareholders' equity | 20 | 10 | 404 | 397 | 20 |
| TOTAL | $-1,770 | $-1,650 | $-1,554 | $-1,365 | $-1,720 |
| Total Liabilities And Equity | $-100 | $60 | $706 | $377 | $20 |